Insilico Medicine

ENTRABB

End-to-end AI drug discovery. INS018_055 Phase II milestone. Sanofi + Exelixis partnerships.

insilico.com

9Featured · #9 of 2026Top 10 Healthcare AI Employers

Boston / Hong KongFounded 2014300+ employeesSeries E · ~$400M raisedBiotech AI · Drug Discovery

Hiring Now

60 open roles at Insilico Medicine

Verified live postings · updated MAR 12, 2026

View all 60 roles

Get notified when Insilico Medicine posts a new role

Free · email when published · no weekly noise

Insilico Medicine

Overview Talent Index Hiring Salary Leadership Coverage Compare

ENTRA Talent Index

Hiring quality verdict.

56/ 100

ENTRABB

Insilico Medicine runs an end-to-end AI drug discovery platform — Pharma.AI plus PandaOmics plus Chemistry42 — that produced INS018_055, the first AI-discovered, AI-designed drug to clear Phase II in idiopathic pulmonary fibrosis. Sanofi and Exelixis partnerships anchor the commercial pipeline. 300+ employees split between Boston, Hong Kong, Shanghai, and Abu Dhabi (the MENA office anchored to G42's healthcare AI thesis).

Hiring Velocity66

Compensation70

Retention70

Mission Alignment78

Methodology · 5 dimensions equally weightedData as of MAR 12, 2026

Hiring Intelligence

Insilico Medicine by the numbers.

Open roles

Verified live postings

Hiring velocity · YoY

+52%

Net-new AI hires (12-month)

Funding stage

Series E · ~$400M raised

Biotech AI · Drug Discovery

Salary Intelligence

Verified salary ranges.

Total comp · USD · annual

Senior ML Researcher

$200Kto$340K

Computational Chemist

$180Kto$300K

Leadership

Who runs talent at Insilico Medicine.

Alex Zhavoronkov

Founder & CEO

Petrina Kamya

President & Head of Pharma.AI

Latest Coverage

Insilico Medicine in ENTRA Intelligence.

LISTGlobal · Biotech

Top 10Healthcare AI Employers 2026

Top 10 Healthcare AI Employers 2026

Abridge anchors the field at $5.3B. Tempus IPO'd. Recursion + Isomorphic Labs reset drug-discovery comp. NHS England runs ~£600M in sovereign procurement. The 10 healthcare AI employers reshaping the senior-IC AI funnel.

MAR 12, 2026HEALTHCARE AIBIOTECH AI

Compare with peers

Insilico Medicine vs. peers.

All companies

Recursion Pharmaceuticals

Biotech AI

Isomorphic Labs

Biotech AI

Owkin

Biotech AI

More coverage

Browse all companies in our editorial coverage.

All Companies